Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
Can Psychedelics Increase Sexual Interest And Satisfaction? Study Says Yes And Effects Can Last Months
A new study suggests a potential link between the use of psychedelics like magic mushrooms and LSD and improved sexual function up to six months after they have been consumed.
Believed to be the first scientific research into the effects of psychedelics and sex, the new findings combine responses from nearly 300 participants who reported overall improvements after a psychedelic experience. Keep reading.
Groundbreaking: FDA Reviews MDMA Therapy For PTSD, Accepts New Drug Application
The Food and Drug Administration (FDA) has recently accepted a New Drug Application (NDA) from Lykos Therapeutics for the use of MDMA-assisted therapy in treating Post-Traumatic Stress Disorder (PTSD).
This decision marks a significant milestone in the journey toward potentially integrating psychedelic-assisted therapies into mainstream medical practice. Lykos has been at the forefront of research on this innovative treatment approach. Keep reading.
Police Seizures Of Psychedelic Mushrooms Increases, New Study Finds
Psilocybin, the psychedelic substance in “magic mushrooms,” has been featured in the media as researchers study its potential clinical applications. Two states have undertaken regulated programs for its effective use and several cities have passed decriminalization measures for a variety of natural psychedelics including these mushrooms.
Yet at the federal level, psilocybin is still illegal. Researchers analyzed data on law enforcement seizures of psychedelic mushrooms to better understand their use prevalence. Keep reading.
Canadians View Psilocybin Therapy As ‘Reasonable Medical Choice’ For End-Of-Life Distress, WA Doctor Requests DEA Approval
A majority of Canadians (79.3% ) consider psilocybin-assisted therapy to be “a reasonable medical choice” for addressing “existential distress” during the final stages of life, a team …